Earnings Feed
Start Free
|8-KFeb 2, 4:21 PM ET

5C Lending Partners Corp. 8-K

Research Summary

AI-generated summary

Updated

5C Lending Partners Amends Revolving Credit Facility, Extends Maturity

What Happened
5C Lending Partners Corp. filed an 8-K on Feb 2, 2026 disclosing a Third Amendment to its revolving credit agreement (entered Jan 30, 2026). The amendment extends the facility’s stated maturity date from January 15, 2027 to January 14, 2028, lowers borrowing margins and fees, modifies how unfunded investor commitments count toward the borrowing base, and temporarily relaxes certain investor concentration limits. The amendment is filed as Exhibit 10.1 to the 8-K.

Key Details

  • Stated maturity extended from Jan 15, 2027 to Jan 14, 2028.
  • Applicable Margin reductions: RFR Loans 2.30% → 1.85%; Eurocurrency Rate Loans 2.30% → 1.85%; Reference Rate Loans 1.30% → 0.85%; Letter of Credit fees 2.30% → 1.85%.
  • Unused commitment fee reduced to 0.25% per year when unused commitments exceed 50% of the facility’s maximum commitment.
  • Borrowing base change: 80% of aggregate unfunded capital commitments of certain investors may be included once the Company has called and received at least 40% of aggregate capital commitments of all investors. Investor concentration limits are amended and certain limits are waived through June 30, 2026.
  • The 8-K also includes Regulation FD disclosure: the Company’s investment portfolio totaled $726.8 million across 21 portfolio companies (loan commitments $670.5M; funded $523.5M; unfunded $147.0M; preferred equity $56.3M). Recent transactions include financing for the acquisition of dentalcorp Holdings Ltd. and a term loan in connection with Excel Sports Management, LLC.

Why It Matters
For investors, the amendment improves the Company’s borrowing economics (lower margins and fees) and extends liquidity runway by one year, while allowing more unfunded investor commitments to support borrowing capacity once certain call thresholds are met. The temporary waiver of concentration limits may affect risk exposure mix in the near term. The portfolio and recent deal disclosures show continued lending and investment activity across healthcare and sports management deals, and the credit amendments may support ongoing financings and follow-on activity.